About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Labcorp and National Kidney Foundation Promote Patient Registry to Enhance Clinical Trial Accessibility, Diversity

Labcorp (NYSE: LH), a leading global life sciences company, and the National Kidney Foundation (NKF), the largest patient organization dedicated to the prevention and treatment of kidney disease, announced their collaboration to promote the NKF Patient Network, the first national registry for chronic kidney disease (CKD) patients in the U.S. The NKF Patient Network will offer greater data and insights to physicians, as well as improved clinical trial access for patients with kidney disease.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211104006383/en/

Photo courtesy of Labcorp.

Photo courtesy of Labcorp.

“The NKF Patient Network is a great advancement in generating high-quality data, and it will facilitate access to more CKD trials and enrollment of more diverse subpopulations,” said Dr. Barbara Gillespie, vice president and nephrology lead, Labcorp Drug Development. “Improvements in screening rates, especially among patients with diabetes, hypertension or both, allow physicians to better identify and appropriately treat those living with CKD, including the consideration of participation in kidney trials.”

The registry is a first-of-its kind, national repository that uses both self-reporting and, with patient consent, electronic health records to obtain vital data. It was created specifically for people in all stages of kidney disease, including dialysis and transplant. More than just a database, the registry also provides resources for patients, who are empowered to share their experiences and explore participation in studies, research and clinical development opportunities. By including additional information from Labcorp about clinical trial opportunities related to CKD, patients and physicians will be able to identify studies that may offer access to advanced treatments and help increase knowledge of the disease.

Patient registries are observational study methods used to collect standardized information about patients who share a condition or experience. The NKF Patient Network registry, which was launched in February 2021, has enrolled more than 1,100 patients across the U.S., with a goal of reaching 2,000 by March 2022.

“The NKF Patient Network is our way of helping to advance education and clinical trials for patients with kidney disease,” said Kerry Willis, Chief Scientific Officer at NKF. “A large, robust registry will give physicians better data and offer patients easier access to groundbreaking trials. In leveraging Labcorp’s vast physician network and clinical trial opportunities, we hope to see continued growth of the registry, ultimately leading to better outcomes for those living with kidney disease.”

This collaboration builds upon an ongoing and growing relationship between the two organizations. In August, Labcorp and NKF announced the results of a study which found millions of patients most at-risk for life-threatening kidney disease are unaware they have it because they are not tested according to clinical practice guidelines despite their risk.

Kidney disease often has no detectable symptoms by the patient, and too often patients only find out they have the disease when their kidneys fail. Early detection is critical to slowing the disease progression. Lifestyle changes, dietary modifications, medical management of risk factors, and therapeutics that protect the kidney can slow kidney disease progression and help protect against cardiovascular complications that are associated with advanced kidney disease.

Risk factors for kidney disease include: diabetes, high blood pressure, heart disease, obesity, and family history. People of Black/African American, Hispanic/Latino, American Indian/Alaska Native, Asian American, or Native Hawaiian/Other Pacific Islander descent are at increased risk for developing the disease. Black/African American people are more than 3 times as likely as White people to have kidney failure. Hispanics/Latinos are 1.3 times more likely than non-Hispanics to have kidney failure.

To learn more about or join the National Kidney Foundation Patient Network, visit: NKFPatientNetwork.org.

About the National Kidney Foundation

The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org and follow us on Facebook and Twitter. To learn more about the registry, visit NKFPatientNetwork.org.

About Labcorp

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With more than 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY2020. Learn about Labcorp at www.Labcorp.com, or follow us on LinkedIn and Twitter @Labcorp.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.